Genomic pathology: Challenges for implementation

Archives of Pathology and Laboratory Medicine

Volumn 135, Issue 8, 2011, Pages 967-968

  Cagle, Philip T ^a   Dacic, Sanja ^b   Allen, Timothy C ^c  

^a HOUSTON METHODIST HOSPITAL   (United States)

^b PRESBYTERIAN UNIVERSITY HOSPITAL   (United States)

^c UNIVERSITY OF TEXAS AT TYLER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GENOMICS; HUMAN; LETTER; METHODOLOGY; MOLECULAR PATHOLOGY; PATHOLOGY;

GENOMICS; HUMANS; PATHOLOGY; PATHOLOGY, MOLECULAR;

EID: 80052020887     PISSN: 00039985     EISSN: 15432165     Source Type: Journal    
DOI: 10.5858/2011-0199-EDI     Document Type: Letter

References (17)

1. Cagle PT, Dacic S. Lung cancer and the future of pathology. Arch Pathol Lab Med. 2011;135(3):293-295.
2. Stratton MR, Campbell PJ, Futreal PA. The cancer genome. Nature. 2009; 458(7239):719-724.
3. Schadt EE, Turner S, Kasarskis A. A window into third-generation sequencing. Hum Mol Genet. 2010;19(R2):R227-R240.
4. Zhao J, Grant SF. Advances in whole genome sequencing technology. Curr Pharm Biotechnol. 2011;12(2):293-305.
5. Wen J, Fu J, Zhang W, Guo M. Genetic and epigenetic changes in lung carcinoma and their clinical implications [published online ahead of print March 18, 2011]. Mod Pathol. doi:10.1038/modpathol.2011.46.
6. Sequist LV, Bell DW, Lynch TJ, Haber DA. Molecular predictors of response to epidermal growth factor receptor antagonists in non-small-cell lung cancer. J Clin Oncol. 2007;25(5):587-595. (Pubitemid 350002967)
7. International Human Genome Sequencing Consortium. Finishing the euchromatic sequence of the human genome. Nature. 2004;431 (7011): 931-945.
8. Lander ES. Initial impact of the sequencing of the human genome. Nature. 2011;470(7333):187-197.
9. American Institute of Physics. The 15-minute genome: faster, cheaper genome sequencing on the way. ScienceDaily. July 29, 2009. http://www. sciencedaily.com/releases/2009/O7/090727191912.htm Accessed April 15, 2011.
10. Singer A, Wanunu M, Morrison W, Kuhn H, Frank-Kamenetskii M, Meller A. Nanopore based sequence specific detection of duplex DNA for genomic profiling. Nano Lett. 2010;10(2):738-742.
11. Korlach J, Bjornson KP, Chaudhuri BP, et al. Real-time DNA sequencing from single polymerase molecules. Methods Enzymol. 2010;472:431-455.
12. Tonellato PJ, Crawford JM, Boguski MS, Saffitz JE. A national agenda for the future of pathology in personalized medicine: report of the proceedings of a meeting at the Banbury Conference Center on genomeera pathology, precision diagnostics and preemptive care: a stakeholder summit. Am J Clin Pathol. 2011;135(51):668-672.
13. Musser JM. Third track pathology: in unambiguous support of the Banbury conference report. Arch Pathol Lab Med. 2011;135(6):687-688.
14. Collins FS. The future has already happened. In: Collins FS. The Language of Life: DNA and the Revolution in Personalized Medicine. New York, NY: HarperCollins; 2010:1-22.
15. Offit K, Thorn P. Ethical and legal aspects of cancer genetic testing. Semin Oncol. 2007;34(5):435-443. (Pubitemid 47503275)
16. Clayton EW, Smith M, Fullerton SM, et al. Confronting real time ethical, legal, and social issues in the Electronic Medical Records and Genomics (eMERGE) Consortium. Genet Med. 2010;12(10):616-620.
17. Collins FS. A vision for the future. In: Collins FS. The Language of Life: DNA and the Revolution in Personalized Medicine. New York, NY: HarperCollins; 2010:251-280.